Stockreport

ASLAN Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

ASLAN Pharmaceuticals Limited - American Depositary Shares  (ASLN) 
US:NASDAQ Investor Relations: ir.aslanpharma.com
PDF  - Next data readout for ASLAN004 in the treatment of patients with moderate to severe atopic dermatitis anticipated in the third quarter of 2021 - Phase 2b clinical tri [Read more]